Pfizer has said this through a statement. (File Photo)
DGCI has exempted vaccines approved by international regulatory bodies from the rules of trial. It is believed that after this decision, the way for foreign vaccine will be opened in India.
New Delhi. American pharma company Pfizer has said that it is in talks with the Indian government regarding vaccine supply. This statement of the company comes after the decision of the Drugs Controller General of India (DGCI) in which some ‘established’ vaccines have been exempted from indigenous trials.
The company said in its statement, ‘Our talks are going on with the central government to provide the vaccine in India’s Corona Vaccination Program. Since we are in talks with the government, we are unable to give much information about it right now.
Pfizer and Moderna’s vaccine may open the way
Let us tell you that DGCI has given exemption in the rules of trial to the vaccine approved by international regulatory bodies. It is believed that after this decision, the way for foreign vaccine will be opened in India. After this, the way for vaccines like Pfizer and Moderna to come to India soon will be opened.Pfizer has said to provide 50 million vaccine doses to India
Earlier, Pfizer had said that it is ready to give 50 million doses of its vaccine to India. The company says that it can give so many doses this year. However, the company has also sought some regulatory relaxations, including compensation rules.
Let us tell you that even when there was talk of giving emergency use to the vaccine in the country, Pfizer had applied. But then only those vaccine candidates were exempted in India who had been tried in the country. On this basis, Covishield and Covaccine were allowed. The Russian vaccine Sputnik-V has also been tried in India. However, now the rules are being changed in view of the demand for the vaccine.